Showing results (51-60 of 61) with videos related to
Sort By:
Pageof 7
Kardiologiia|December 17, 2004
[Antiarrhythmic Efficacy of a New Class III Antiarrhythmic Drug RG-2.]V V Fedorov, L V Rozenshtraukh, A V Reznik, et al.Kardiologiia|November 1, 2003
[Ionic mechanisms of cardiotropic action of a new class III antiarrhythmic drug RG-2]A V Reznik, V V Fedorov, Iu M Kokoz, et al.Vestnik Otorinolaringologii|May 28, 2024
[Bilateral vestibulopathy and sensorineural hearing loss in necrobiotic xanthogranuloma, multiple myeloma and amiloidosis]E V Reznik, A L Guseva, A A Yasnovskaya, et al.Kardiologiia|September 2, 2004
[Anticholinergic Effect of a New Antiarrhythmic Class III Drug RG-2]V V Fedorov, I A Ivanova, A V Glukhov, et al.Kardiologiia|November 1, 2003
[Electrophysiological experimental study of a novel class III antiarrhythmic drug RG-2]L V Rozenshtraukh, V V Fedorov, A V Reznik, et al.Terapevticheskii Arkhiv|May 10, 2026
[Cardiorenal syndrome in an 85-year-old patient with neurofibromatosis. Case report]E V Reznik, T A Gaydina, E A Koltsova, et al.Terapevticheskii Arkhiv|June 25, 2025
[Treatment of a patient with relapsing polychondritis: Case report]E V Reznik, Y Y Golubev, N V Yurtayeva, et al.International Journal of Molecular Sciences|October 16, 2024
Histopathological and Immunohistochemical Characteristics of Different Types of Cardiac AmyloidosisZarina V Gioeva, Liudmila M Mikhaleva, Nikita A Gutyrchik, et al.Journal of Clinical Medicine|June 12, 2026
Prolonged Infections and Inflammatory Diseases in Common Variable Immune Deficiency as a Cause of AA AmyloidosisElena V Reznik, Maksim D Iarovoi, Tatiana S Romanova, et al.Terapevticheskii Arkhiv|June 30, 2020
[Galactin-3: diagnostic and prognostic value in patients with chronic heart failure]A M Aliyeva, I E Baykova, V A Kislyakov, et al.Pageof 7